Skip to main content
Top of the Page
Drugs

Elimination of Buprenorphine Dose Limits

The WSMA supports flexibility in dosing of buprenorphine by elimination of non-evidence-based dose limits imposed by clinics, health systems, pharmacies, and insurance carriers. (Res B-5, A-23)


Return to the WSMA Policy Compendium index


Abbreviations for House of Delegates report origination:

EC – Executive Committee; BT – Board of Trustees; CPA – Council on Professional Affairs; JC – Judicial Council; CHS – Community and Health Services

Join or renew your membership today!